• 文献标题:   Acid-Triggered Charge-Convertible Graphene-Based All-in-One Nanocomplex for Enhanced Genetic Phototherapy of Triple-Negative Breast Cancer
  • 文献类型:   Article
  • 作  者:   WU CH, TIAN Y, ZHANG YX, XU JM, WANG YK, GUAN XT, LI TT, YANG H, LI S, QIN X, LIU YY
  • 作者关键词:   acidresponsive nanocarrier, chargeconversion, combination therapy, mirna21, phototherapy
  • 出版物名称:   ADVANCED HEALTHCARE MATERIALS
  • ISSN:   2192-2640 EI 2192-2659
  • 通讯作者地址:   Univ Elect Sci Technol China
  • 被引频次:   1
  • DOI:   10.1002/adhm.201901187 EA DEC 2019
  • 出版年:   2020

▎ 摘  要

Highly efficient and stimulus-responsive nanomedicines for cancer treatment are currently receiving tremendous attention. In this study, an acid-triggered charge-reversible graphene-based all-in-one nanocomplex is appropriately designed by surface modification with multilayer polymers and simultaneous co-transportation of photosensitizer indocyanine green (ICG) and oligonucleotide inhibitor of miR-21 (miR-21i) to achieve highly efficient genetic phototherapy in a controlled manner. The nanocomplex (denoted as GPCP/miR-21i/ICG) effectively protects miR-21i from degradation and exhibits excellent photothermal/photochemical reactive oxygen species (ROS) generation as well as fluorescence imaging ability. The cargoes ICG and miR-21i can significantly be released at acidic pH compared with normal physiological medium and escaped from endosomes/lysosomes due to the acid-triggered charge reversal effect. Typically, the released miR-21i downregulate the endogenous miR-21 and result in the upregulation of the target proteins PTEN and Bax, thus increasing the phototherapeutic efficiency of ICG. High in vivo anticancer efficiency against the MDA-MB-231 triple-negative breast cancer (TNBC) model is obtained due to the combination of genetic regulation of miR-21i and the photokilling effect of ICG. This work highlights the great potential of this smart nanocomplex as an attractive modality of gene-photo combined treatment of cancer, especially for intractable TNBC.